Cat.#: ACPP-1366
Despition | Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1444 | Human VAMP2 Protein (AC1444) | 5 µg | inquiry |
ACPP-1274 | Visfatin Blocking Peptide (AC1274) | 250 µg | inquiry |
ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
ACPP-1786 | Human FGF 1 Protein (AC1786) | 10 µg | inquiry |
ACPP-1416 | Human VAMP1 Protein (AC1416) | 20 µg | inquiry |
ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
ACPP-1427 | Human ASMT Protein (AC1427) | 5 µg | inquiry |
ACPP-1546 | Human HNMT Protein (AC1546) | 5 µg | inquiry |
ACPP-1637 | Human NRN1 Protein, His (AC1637) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.